redirecting...

Webcast
Q1 2017 Allergan plc Earnings Conference Call (Live)
05/09/17 at 8:30 a.m. ET
Keyword Search
04.28.2017
Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition
04.25.2017
Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production
04.20.2017
Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheimer's Disease at the American Academy of Neurology Meeting in Boston
04.20.2017
Allergan Partners with TARGET PharmaSolutions to Advance NASH Research
04.18.2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
<>